Image1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

Table1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.docx by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

Image3_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

Image2_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

DataSheet1_Chrysanthemum indicum L. ameliorates muscle atrophy by improving glucose tolerance in CT26-induced cancer cachexia.docx by Gahee Song (8933261)

“…After 1 week, the mice were orally administered vehicle, CI (100 mg/kg), or Celecoxib (50 mg/kg) for 3 weeks.</p>Results<p>CI improved loss of body weight and impaired glucose tolerance, but celecoxib did not recover the body weight and glucose intolerance. …”

Image3_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

DataSheet1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.docx by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

Image1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

DataSheet1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.docx by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

Image2_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

Table1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.docx by Chang-hong Li (11816780)

“…In vivo, ovariectomized mice were treated with 50, 100 and 200 mg/kg/d NTZ for 3 months. NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity. …”

Table_3_Flammulinavelutipes Polysaccharides Modulate Gut Microbiota and Alleviate Carbon Tetrachloride-Induced Hepatic Oxidative Injury in Mice.XLS by Yingyin Xu (10507772)

Matlab Code File 3: Helper Function from Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition by Wei He (131453)

Mechanism of Absorption Wavelength Shift of Bacteriorhodopsin During Photocycle by Tomoyasu Noji (1280301)

Comparison of cerebrospinal fluid lactate with physical, cytological, and other biochemical characteristics as prognostic factors in acute bacterial meningitis by Sérgio Monteiro De Almeida (8303331)

Effect of Azithromycin on TGFβ1-induced EMT of primary human small and large airway epithelial cell cultures – expression of epithelial and mesenchymal markers. by Balarka Banerjee (107946)

“…Further quantification of the immunoblots showed a suppression in theincrease in expression of mesenchymal markers (B) vimentin (Vim) and (C) EDA- Fibronectin (EDA-Fn), and the decrease in expression of epithelial markers (D) Zona Occludens -1 (ZO-1) and (E) Cytokeratin-19 (Ck-19) in SAEC and LAEC, observed in the control samples which were stimulated with TGFβ1 alone (n = 6). …”

Comparing metabolic profiles of DTT and AN5568 treated cells. by Pieter C. Steketee (466154)

“…In particular, DTT treatment led to a significant decrease in trypanothione disulphide. …”

Table_2_Flammulinavelutipes Polysaccharides Modulate Gut Microbiota and Alleviate Carbon Tetrachloride-Induced Hepatic Oxidative Injury in Mice.XLSX by Yingyin Xu (10507772)

Balloon-Expandable Transcatheter Mitral Valve Replacement Through Minimally Invasive Approach in Big MAC by Daiana Nerea Romero (9647253)

“…Lastly, the attachment of the pericardial patch within the atrium was performed with a circumferential running suture with a 5.0 polypropylene suture. …”

Simulations suggest spatial confinement causes the late-stage rearrangement of sarcolytes. by Daiki Wakita (8080223)

“…<p>Parameter changes to slow down the muscle units were performed from 30 to 50 hAPF (steps 129,600–273,600). (a–e) Snapshots of the left halves of simulation fields at 40 and 50 hAPF: (a) spatial confinement, (b) decrease in the self-propelling force strength of hemocytes, (c) increase in the friction coefficient of all the particles, (d) increase in the adhesion strength between a hemocyte and a fat body cell, (e) increase in the adhesion strength between hemocytes. …”